2014
DOI: 10.1038/cr.2014.91
|View full text |Cite
|
Sign up to set email alerts
|

Regeneration: making muscle from hPSCs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 11 publications
(22 reference statements)
0
5
0
Order By: Relevance
“…In recent years, several protocols have been reported to propagate human myogenic progenitors from pluripotent cell sources and to differentiate these progenitors into the skeletal muscle cell lineage as myoblasts or myotubes (Zhu et al, 2014). While many protocols require cell sorting and/or rely on exogenous expression of myogenic genes such as PAX3, PAX7, and MYOD (Abujarour et al, 2014; Darabi et al, 2012; Maffioletti et al, 2015; Skoglund et al, 2014; Tanaka et al, 2013), more recent advances have been made with the application of small molecules and growth factors to directly promote myogenic differentiation from human iPSCs (Barberi et al, 2007; Borchin et al, 2013; Caron et al, 2016; Chal et al, 2016; Chal et al, 2015; Choi et al, 2016; Hosoyama et al, 2014; Hwang et al, 2013; Shelton et al, 2014; Xu et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, several protocols have been reported to propagate human myogenic progenitors from pluripotent cell sources and to differentiate these progenitors into the skeletal muscle cell lineage as myoblasts or myotubes (Zhu et al, 2014). While many protocols require cell sorting and/or rely on exogenous expression of myogenic genes such as PAX3, PAX7, and MYOD (Abujarour et al, 2014; Darabi et al, 2012; Maffioletti et al, 2015; Skoglund et al, 2014; Tanaka et al, 2013), more recent advances have been made with the application of small molecules and growth factors to directly promote myogenic differentiation from human iPSCs (Barberi et al, 2007; Borchin et al, 2013; Caron et al, 2016; Chal et al, 2016; Chal et al, 2015; Choi et al, 2016; Hosoyama et al, 2014; Hwang et al, 2013; Shelton et al, 2014; Xu et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…Despite the progress that has been made with rodent cells, the current methods used to expand primary, human muscle stem cells in vitro remain inefficient and, thus, the use of human induced pluripotent stem cells (iPSCs) holds the promise of providing unlimited numbers of patient-specific myogenic cells for disease modeling and autologous cell therapies (101). During the past 3 years, myogenic cells have been derived from human iPSCs from normal individuals and those with different congenital muscle diseases by forcing expression of muscle transcription factors PAX7 (102, 103) or MYOD (104107) using doxycycline-inducible lentiviral and transposon vectors.…”
Section: Bioengineering Methods For Skeletal Muscle Research and Rmentioning
confidence: 99%
“…Other methods for inducing myogenic differentiation have been demonstrated in cultured mammalian cells (Zhu et al 2014 ) but not reported in fish. The reported strategies rely on myogenic inducers such as a specific skeletal muscle cell growth medium (SkGM™)-2 BulletKit™ (Lonza) containing human epidermal growth factor (hEGF), fetuin, FBS, dexamethasone, and insulin, supplemented with 5-azacytidine (Stern-Straeter et al 2014 ; Okamura et al 2018 ).…”
Section: Myogenesis In Fishmentioning
confidence: 99%